Search Results - "Martí, M. Climente"

A Bayesian method for predicting 5-fluorouracil pharmacokinetic parameters following short-term infusion in patients with colorectal cancer by Climente-Martí, M, Merino-Sanjuán, M, Almenar-Cubells, D, Jiménez-Torres, N V

“…The objective of this study was to develop a population pharmacokinetic model and validate it using a Bayesian approach for predicting, a priori and a…”
Get more information

3PC-020 Chemical stability and physical compatibility of insulin eye drops used in clinical practice by Martínez Gómez, MA, Martínez Albaladejo, P, Ricoy Sanz, I, Bravo Crespo, C, Polo Durán, J, Llopis Alemany, A, Giménez Giner, S, Cercós Lletí, AC, Climente Martí, M

“…Background and importanceInsulin eye drops are an effective treatment for corneal neurotrophic ulcers due to the action of insulin as a tissue growth factor…”
Get full text

3PC-021 Impact of a centralised intravenous additive service in patients and healthcare workers risk reduction by Marcos Fendián, Á, Sancho Artés, A, Llopis Salvia, P, Climente Martí, M

“…BackgroundParenteral drug compounding and its administration carries potential risks for patients. Safe handling procedures avoid healthcare workers’ exposure…”
Get full text

Development and application to clinical practice of a validated HPLC method for the analysis of β-glucocerebrosidase in Gaucher disease by Colomer, E. Gras, Gómez, M.A. Martínez, Álvarez, A. González, Martí, M. Climente, Moreno, P. León, Zarzoso, M. Fernández, Jiménez-Torres, N.V.

“…•Development and validation of a simple, fast and reliable method for estimation of glucocerebrosidase activity based on high-performance liquid…”
Get full text

CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy by Gómez-Álvarez, S, Llopis-Salvia, P, Avila-Bernabeu, A, Pallardó-Mateu, L, Climente-Martí, M

“…BackgroundAtypical haemolytic uraemic syndrome (aHUS) is a rare, life-threatening, chronic thrombotic microangiopathy (TMA) caused by uncontrolled complement…”
Get full text

PKP-018 Relationship of serum valproic acid concentrations with unbound valproic acid concentrations in the malnourished patient by Martínez-Moreno, J, Mud-Castelló, S, López-Navarro, A, Ordovás-Baines, JP, Gómez-Álvarez, S, Saez-Belló, M, Climente-Martí, M

“…BackgroundValproic acid is an antiepileptic that has a broad antiepileptic spectrum with high protein binding. Due to the large variability in protein binding,…”
Get full text

CP-162 Effectiveness and safety of pirfenidone in idiopathic pulmonary fibrosis by Martínez-Moreno, J, López-Navarro, AA, Ventura-Cerdá, JM, Gómez-Álvarez, S, Climente-Martí, M

“…BackgroundIdiopathic pulmonary fibrosis (IPF) is a fatal pulmonary disease with few therapeutic alternatives. Pirfenidone is the first drug that has shown…”
Get full text

3PC-008 Times and errors for dispensing narcotic drugs in automated system versus manual system by Martínez Albaladejo, P, Ricoy Sanz, I, Saez Bello, M, Ordovas Baines, JP, Climente Marti, M

“…Background and importanceNarcotic drugs require a special control and monitoring by the Pharmacy Service (PS) to ensure their correct storage and dispensing…”
Get full text

391 Pharmaceutical interventions on medicines reconciliation during CF paediatric patient's admission by Chorro-Mari, V, Gomez-Pastrana, D, Climente-Marti, M, Merino-Sanjuan, M, Christiansen, N, Pao, C, Nwokoro, C, Brown, S

Get full text

390 Evaluation of a potential impact of specialist cystic fibrosis (CF) pharmacist in the quality of discharge prescriptions in paediatric CF patients by Chorro-Mari, V, Gomez-Pastrana, D, Christiansen, N, Pao, C, Nwokoro, C, Brown, S, Climente-Marti, M, Merino-Sanjuan, M

Get full text

4CPS-149 Time of permanence in second or successive lines of treatment with anti-tnf drugs vs other biological drugs in patients with inflammatory arthropathies by Bello, M Saez, Salvia, P Llopis, Caudevilla, M Hermenegildo, Benavides, J Martínez, Martí, M Climente, Sancho, JJ Alegre

“…BackgroundThe number of biologic drugs with indication in inflammatory arthopathies is still limited. Because of this we should understand which factors can…”
Get full text

Doctors' acceptance of recommendations for patients with the opportunity for pharmacotherapy improvement by López-Montenegro Soria, M A, Climente Martí, M, Jiménez Torres, N V

“…To identify and quantify the influence of different variables on the implementation of pharmacotherapy optimisation measures in hospitalised patients…”
Get full text

Machine-learning-derived predictive score for early estimation of COVID-19 mortality risk in hospitalized patients by González-Cebrián, Alba, Borràs-Ferrís, Joan, Ordovás-Baines, Juan Pablo, Hermenegildo-Caudevilla, Marta, Climente-Marti, Mónica, Tarazona, Sonia, Vitale, Raffaele, Palací-López, Daniel, Sierra-Sánchez, Jesús Francisco, Saez de la Fuente, Javier, Ferrer, Alberto

“…The clinical course of COVID-19 is highly variable. It is therefore essential to predict as early and accurately as possible the severity level of the disease…”
Get full text

Pharmacotherapy quality and patient safety in haemodialysis patients treated with erythropoiesis-stimulating agents by de Diego Santos, T, Climente Martí, M, Albert Balaguer, E V, Jiménez Torres, N V

“…To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are…”
Get full text

Aceptación de recomendaciones en el paciente con oportunidades de mejora farmacoterapéutica by López-Montenegro Soria, M.A., Climente Martí, M., Jiménez Torres, N.V.

“…Identificar y cuantificar la influencia de diferentes variables en la implantación de medidas de optimización farmacoterapéutica en pacientes ingresados…”
Get full text

Quality assessment of two pharmaceutical care models for onco-haematological patients by Cavero Rodrigo, E, Climente Martí, M, Navarro Fontestad, M C, Jiménez Torres, N V

“…To compare the quality of two pharmaceutical care models (with and without pharmacist participation in the clinical team), in hospitalised onco-haematological…”
Get full text

Vancomycin or linezolid as the treatment of choice for grampositive nosocomial pneumonia by Márquez-Peiró, J F, Climente-Martí, M, Jiménez-Torres, N V

Get full text

Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use by López Navarro, Alfonso Ángel, Martínez Gómez, María Amparo, Gras Colomer, Elena, Campillos, Pilar, Climente Martí, Mónica

“…BackgroundIntravenous admixtures of dexketoprofen-trometamol and paracetamol are frequently used in clinical practice due to synergism obtained administering…”
Get full text

Vancomicina o kinezolid en el tratamiento de elección para la neumonía nosocomial por grampositivos by Márquez-Peiró, J.F., Climente-Martí, M., Jiménez-Torres, N.V.

Get full text

Effectiveness and safety of Very Low Calory Diets in obese patients by Sáez Belló, M, Segarra Villalba, C, Gras Colomer, E, Frias Ruiz, P, Climente Martí, M

“…To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. Observational prospective descriptive study. Patients…”
Get more information